In 2010, the FDA recognized that Lamictal; a medicine primarily used to treat seizures in children and Bipolar Disorder in adults, can cause Stevens-Johnson syndrome and Aseptic Meningitis – a severe inflammation of the membranes in the brain and spinal cord.
Manufactured by GlaxoSmithKline, Lamictal may also treat Bipolar Disorder in adults. The FDA is revising Lamictal’s black box warning on its drug label to warn about the risks carried with taking Lamictal and its possibility to cause Aseptic Meningitis when given to patients. GlaxoSmithKline agreed to change the label in adherence to the FDA’s warnings.
Russell Katz, Director of the FDA’s neurology-products division said in a statement “Aseptic Meningitis is a rare but serious side effect of Lamictal use. Patients that experience symptoms should consult their health-care professional immediately.”
Symptoms of Aseptic Meningitis are fever, headache, nausea, rash, sensitivity to light, stiff neck, and vomiting.
According to the FDA, from December 1994 to November 2009 – of the 40 cases of patients taking Lamictal, 35 were hospitalized because of their Aseptic Meningitis symptoms; Those symptoms were resolved shortly after Lamictal was discontinued. For 15 of those patients, symptoms returned quickly after restarting Lamictal. Because of this, the FDA decided to revise the Lamictal label. During the same time period, over 46million prescriptions for Lamictal were filled.
If you or a loved one has suffered from SJS, was diagnosed with Aseptic Meningitis, or had a child who was born disfigured, contact Wormington & Bollinger’s team of lawyers to fight for you and your right to be compensated for your injuries.